Phychem Technologies IPO Day 3: Issue subscribed 3.13x so far. Check issue details and key dates

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Phychem Technologies IPO subscribed 3.13 times by end of Day 3.
  • NII (bHNI) category jumped 34.7% in the final hours of bidding.
  • Retail subscription rose to 2.94x, up from 2.30x earlier in the day.
  • QIB category remained stable at 3.53x throughout the issue.
  • Allotment expected on September 3, 2026; listing on September 7, 2026.
powered bylight_fuzz_icon
49873849

*this image is generated using AI for illustrative purposes only.

Phychem Technologies IPO concluded its bidding on Day 3 with an overall subscription of 3.13x. The issue saw a significant late-day surge, with Non-Institutional Investors (bHNI) jumping 34.7% and Retail investors adding 27.8% in the final hours. Qualified Institutional Buyers (QIB) drove early demand, subscribing 3.53 times.

Final Subscription Status

The IPO opened on August 31, 2026, and closed on September 2, 2026. Below is the day-wise subscription progression:

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 31-08-2026 3.53x 0.24x 0.62x 0.13x 1.17x
Day 2 01-09-2026 3.53x 1.24x 1.47x 1.32x 1.96x
Day 3 02-09-2026 3.53x 2.33x 3.40x 2.94x 3.13x

Intra-day Timeline (Day 3)

Momentum picked up sharply in the final session. Here is the hourly pace on September 2, 2026:

Time (IST) QIB NII (bHNI) Retail Total
11:15 3.53x 1.73x 2.30x 2.62x
12:15 3.53x 2.33x 2.94x 3.13x

Category-wise Breakdown

  • QIB: Subscribed 3.53 times. This category remained stable throughout the bidding period.
  • NII (bHNI): Subscribed 2.33 times by end of Day 3, showing significant growth from 1.73x earlier in the day.
  • NII (sHNI): Subscribed 3.40 times.
  • Retail: Subscribed 2.94 times, picking up pace in the final hours with a 27.8% jump.

About the Company

Phychem Technologies Limited is engaged in manufacturing rotational molding compounds, which serve as key raw materials for producing hollow plastic products. Founded in 2013, the company supplies customized polyethylene-based compounds to industries including building and construction, water management, agriculture, automotive, and consumer products. The company is led by MD Umakant Nivrutti Savadekar and CFO Ulka Umakant Savadekar.

Financial Highlights

The company has shown consistent revenue growth over the last three years. Key standalone financials are as follows:

Particulars FY 2024 FY 2025 FY 2026
Revenue from Operations (₹ crores) 46.97 50.30 56.47
Total Profit/PAT (₹ crores) 1.69 2.84 4.09
Total Equity (₹ crores) 6.86 9.70 13.79

Revenue grew from ₹46.97 crores in FY 2024 to ₹56.47 crores in FY 2026. Total profit increased from ₹1.69 crores to ₹4.09 crores in the same period.

Objects of the Issue

The net proceeds from the IPO will be utilized for the following purposes:

  • Repayment in full or in part, of certain outstanding borrowings: ₹2.50 crores
  • Funding the capital expenditure towards procurement of plant and machinery: ₹5.15 crores
  • Funding to meet working capital requirements: ₹3.00 crores
  • General Corporate Purpose: Amount not specified in lakhs

Risk Factors

  • Dependence on Manufacturing Facility: The company operates from a single facility in Nashik, making it vulnerable to operational disruptions.
  • Customer Concentration: Top 10 customers contribute approximately 50-53% of revenue, with no long-term agreements in place.
  • Supplier Concentration: A single largest supplier contributes over 60% of purchases, exposing the company to supply disruptions.

What's Next

  • Allotment Date: September 3, 2026
  • Listing Date: September 7, 2026
  • Basis of Allotment: Pro-rata basis as per SEBI regulations for oversubscribed issues.

How might the heavy reliance on a single manufacturing facility in Nashik impact Phychem's ability to meet increased demand post-listing?

What are the potential risks associated with the company's high customer concentration, given the absence of long-term supply agreements?

Will the allocation of ₹5.15 crores for plant and machinery procurement be sufficient to mitigate the supply chain vulnerability posed by a single dominant supplier?

like19
dislike

Phychem Technologies IPO Day 2 Live: Total at 1.96x, Retail surges 120% - Check analysts view and more

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights
  • Phychem Technologies IPO subscription reached 1.96x on Day 2.
  • Retail category surged 120% intra-day to close at 1.32x.
  • NII (bHNI) jumped 113.8% to 1.24x, showing strong individual investor interest.
  • QIB remains fully subscribed at 3.53x throughout the day.
  • The issue closes on 02-09-2026 with listing scheduled for 07-09-2026.
powered bylight_fuzz_icon
49787590

*this image is generated using AI for illustrative purposes only.

Phychem Technologies IPO concluded its bidding on Day 3 with an overall subscription of 3.13x. The issue saw a significant late-day surge, with Non-Institutional Investors (bHNI) jumping 34.7% and Retail investors adding 27.8% in the final hours. Qualified Institutional Buyers (QIB) drove early demand, subscribing 3.53 times.

Final Subscription Status

The IPO opened on August 31, 2026, and closed on September 2, 2026. Below is the day-wise subscription progression:

Day Date QIB NII (bHNI) NII (sHNI) Retail Total
Day 1 31-08-2026 3.53x 0.24x 0.62x 0.13x 1.17x
Day 2 01-09-2026 3.53x 1.24x 1.47x 1.32x 1.96x
Day 3 02-09-2026 3.53x 2.33x 3.40x 2.94x 3.13x

Intra-day Timeline (Day 3)

Momentum picked up sharply in the final session. Here is the hourly pace on September 2, 2026:

Time (IST) QIB NII (bHNI) Retail Total
11:15 3.53x 1.73x 2.30x 2.62x
12:15 3.53x 2.33x 2.94x 3.13x

Category-wise Breakdown

  • QIB: Subscribed 3.53 times. This category remained stable throughout the bidding period.
  • NII (bHNI): Subscribed 2.33 times by end of Day 3, showing significant growth from 1.73x earlier in the day.
  • NII (sHNI): Subscribed 3.40 times.
  • Retail: Subscribed 2.94 times, picking up pace in the final hours with a 27.8% jump.

About the Company

Phychem Technologies Limited is engaged in manufacturing rotational molding compounds, which serve as key raw materials for producing hollow plastic products. Founded in 2013, the company supplies customized polyethylene-based compounds to industries including building and construction, water management, agriculture, automotive, and consumer products. The company is led by MD Umakant Nivrutti Savadekar and CFO Ulka Umakant Savadekar.

Financial Highlights

The company has shown consistent revenue growth over the last three years. Key standalone financials are as follows:

Particulars FY 2024 FY 2025 FY 2026
Revenue from Operations (₹ crores) 46.97 50.30 56.47
Total Profit/PAT (₹ crores) 1.69 2.84 4.09
Total Equity (₹ crores) 6.86 9.70 13.79

Revenue grew from ₹46.97 crores in FY 2024 to ₹56.47 crores in FY 2026. Total profit increased from ₹1.69 crores to ₹4.09 crores in the same period.

Objects of the Issue

The net proceeds from the IPO will be utilized for the following purposes:

  • Repayment in full or in part, of certain outstanding borrowings: ₹2.50 crores
  • Funding the capital expenditure towards procurement of plant and machinery: ₹5.15 crores
  • Funding to meet working capital requirements: ₹3.00 crores
  • General Corporate Purpose: Amount not specified in lakhs

Risk Factors

  • Dependence on Manufacturing Facility: The company operates from a single facility in Nashik, making it vulnerable to operational disruptions.
  • Customer Concentration: Top 10 customers contribute approximately 50-53% of revenue, with no long-term agreements in place.
  • Supplier Concentration: A single largest supplier contributes over 60% of purchases, exposing the company to supply disruptions.

What's Next

  • Allotment Date: September 3, 2026
  • Listing Date: September 7, 2026
  • Basis of Allotment: Pro-rata basis as per SEBI regulations for oversubscribed issues.

Will the aggressive late-day retail bidding sustain through the final day of subscription, or is there a risk of profit-booking before allotment?

How might Phychem Technologies' heavy reliance on a single supplier for over 60% of purchases impact its margin stability post-IPO?

Given the high customer concentration with top clients contributing over 50% of revenue, what strategies does management have to diversify its client base?

like18
dislike